Reference
Chu Z. Abemaciclib plus fulvestrant for the treatment of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer with cystic brain metastases: A case report and literature review. Frontiers in Oncology 12: 30 Nov 2022. Available from: URL: http://www.frontiersin.org/Oncology/about
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1955, 42 (2023). https://doi.org/10.1007/s40278-023-38289-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-023-38289-3